November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Ivy Riano: Scalable radiation oncology practices for future health crises in LMICs
Aug 22, 2024, 14:00

Ivy Riano: Scalable radiation oncology practices for future health crises in LMICs

César U. Alas, PhD student at Dartmouth, shared a post by Ivy Riano on X, adding:

“Proud to share our last research project, where we evaluated 24 radiotherapy innovations during the pandemic across 11 oncology centers in Latin America and the Caribbean.

These practices, prove to be safe, efficient, and applicable in future public health crises.”

Quoting Ivy Riano’s post:

Published:

Our NIH-funded CLARO PARTE study for Latin America and the Caribbean Countries suggests scalable practices in radiation oncology clinics to guide actions during future large-scale public health crises in low- and middle-income countries.”

Kelly Meza, Research assistant at commented on Ivy Riano’s post:

“Congratulations Ivy Riano, Amazing work!”

Source: César U. Alas/X, Ivy Riano/X and Kelly Meza/X

Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries.

Authors: Ivy Riano, César Alas-Pineda, Sarahi Reyes Garcia, Raúl Murillo, Francisco Gutiérrez-Delgado, Eduardo Cazap, Celia Maria Pais Viegas, Marcela de la Torre, Kaory C. Barahona, Gustavo J. Sarria, Ramón del Castillo Bahi, Álvaro Luongo-Céspedes, Beatriz Ovalles, Flory Vanessa Umaña Herrera, Ricardo Sánchez, Shauna McVorran, Benjamin Williams, Joseph Kascmar, Linda S. Kennedy, Kathleen D. Lyons, Suyapa Bejarano, and Sandra L. Wong.

Ivy Riano

Ivy Riano is a third-year Hematology and Medical Oncology Fellow and the Research Chief Fellow at Dartmouth Cancer Center. Additionally, she serves as an Instructor of Medicine at the Geisel School of Medicine at Dartmouth.

She is an active member of the Trainee and Early Career Committee Advisory Group at ASCO and holds the position of Fellow Liaison at the ASCO State Affiliate Council (SAC). Her clinical interests focus on developing novel combinations of immunotherapy for treating patients with non-small cell lung cancer (NSCLC).